FRANKFORT, Ky. (AP) � Kentucky may not have enough monoclonal antibody courses to meet the rising demand in the state, Gov. Andy Beshear says. The federal government is rationing the treatments in response to a national shortage, which may limit Kentucky’s ability to give the medicine to anyone who would need it. Beshear said Thursday

A photograph of people laying down on the floor in pain while waiting for antibody infusions at a treatment site in Jacksonville, Florida, has become a vivid illustration of the huge demand for COVID-19 drugs amid a surge in infections. Monoclonal antibodies remain one of a handful of therapies that can blunt the worst effects